MAPKAP kinase‐2; a novel protein kinase activated by mitogen‐activated protein kinase.
David Stokoe(Enzo Life Sciences (United States)), Patricia T.W. Cohen(Universidade do Estado do Pará), Hisashi Hidaka(Kitasato University), C. J. Marshall(Institute of Cancer Research), David G. Campbell(University of Dundee), Sara Nakielny(Howard Hughes Medical Institute), Sally J. Leevers(The Honourable Society of Lincoln's Inn)
Cited by 481
Related Papers
Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells.
|Journal of Biological Chemistry|1990|1.5k
Molecular Determinants of the Response of Glioblastomas to EGFR Kinase Inhibitors
|New England Journal of Medicine|2005|1.4k
A Pharmacological Map of the PI3-K Family Defines a Role for p110α in Insulin Signaling
|Cell|2006|1.2k
KN-62, 1-[N,O-bis(5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4-phenylpiperazi ne, a specific inhibitor of Ca2+/calmodulin-dependent protein kinase II.
|Journal of Biological Chemistry|1990|625